Topical Therapy for Prevention of Infections in Preterm Infants
NCT00162747 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 600
Last updated 2005-09-13
Summary
The purpose of this study is to determine how to best take care of the skin of preterm infants in order to prevent infections through the skin.
Conditions
- Skin Diseases
Interventions
- DRUG
-
Aquaphor
- DRUG
-
Sunflower Seed Oil
Sponsors & Collaborators
-
Johns Hopkins Bloomberg School of Public Health
lead OTHER
Principal Investigators
-
Gary L Darmstadt, MD · Johns Hopkins Bloomberg School of Public Health
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 7 Months
- Max Age
- 8 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2001-12-31
- Completion
- 2005-06-30
Countries
- Bangladesh
Study Locations
More Related Trials
-
Hyperbilirubinemia in Full-term Neonates
NCT06238349 ·Status: RECRUITING ·Phase: PHASE4
-
Topical Emollient Therapy
NCT01396642 ·Status: COMPLETED ·Phase: NA
-
Safety of Skin Cleansing With Chlorhexidine in Preterm Low Birth Weight Infants
NCT00947518 ·Status: COMPLETED ·Phase: NA
-
The Baby Lung Study
NCT05152316 ·Status: COMPLETED
-
The Effect of Lipid Emulsions on Free Fatty Acids and Free Bilirubin in Premature Newborns
NCT03857646 ·Status: COMPLETED ·Phase: PHASE4
-
The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary Dysplasia
NCT00926276 ·Status: COMPLETED ·Phase: PHASE4
-
Surfactant for Neonatal Respiratory Distress Syndrome(NRDS) and Neonatal Acute Respiratory Distress Syndrome(NARDS)
NCT04777760 ·Status: RECRUITING
-
Vitamin A Supplementation for Extremely-Low-Birth-Weight Infants
NCT01203488 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Twice Daily Application of Coconut Oil in Reducing Water Loss From Skin of Premature Babies in First Week of Life
NCT01758068 ·Status: COMPLETED ·Phase: NA
-
Emollient Therapy for Premature Infants in Zimbabwe
NCT05461404 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Surfactant Using a Supraglottic Airway Device in Late Preterm to Early Term Infants
NCT07176117 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Optimal Dose of Surfactant for Preterm Infants With Respiratory Distress Syndrome
NCT04984057 ·Status: UNKNOWN ·Phase: NA
-
UK Baby Study Using a Baby Wash and Lotion Regimen
NCT03142984 ·Status: TERMINATED ·Phase: NA
-
Duodenal Feeds in Very Low Birth Weight Infants
NCT04246333 ·Status: COMPLETED ·Phase: NA
-
Recombinant Surfactant Protein D (rfhSP-D) to Prevent Neonatal Chronic Lung Disease
NCT05898633 ·Status: COMPLETED ·Phase: PHASE1
-
Enteral High-dose DHA Supplementation on Bronchopulmonary Dysplasia in Very Preterm Infants: a Collaborative Study
NCT05915806 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Effect of Surfactant Dose on Outcomes in Preterm Infants With RDS
NCT03808402 ·Status: COMPLETED
-
Brain Oxygenation and Function of Preterm Newborns During Administration of Two Different Surfactant Preparations
NCT01941524 ·Status: COMPLETED ·Phase: PHASE4
-
Surfactant Versus Nasal Continuous Positive Airway Pressure (nCPAP) for Respiratory Distress Syndrome in the Newborn ≥ 35 Weeks of Gestation
NCT01306240 ·Status: TERMINATED ·Phase: PHASE3
-
Exogenous Surfactant in Very Preterm Neonates in Prevention of Bronchopulmonary Dysplasia
NCT01039285 ·Status: COMPLETED ·Phase: PHASE4
-
First In Human Study on Synthetic Surfactant CHF 5633 in Respiratory Distress Syndrome
NCT01651637 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Using Oxygen on the Diaper Dermatitis in Infants
NCT05427760 ·Status: COMPLETED ·Phase: NA
-
Surfactant for Neonate With Acute Respiratory Distress Syndrome (ARDS)
NCT03217162 ·Status: UNKNOWN ·Phase: NA
-
Does The Surfactant Administration by Aerosolization Effective?
NCT02825953 ·Status: UNKNOWN ·Phase: NA
-
Early NCPAP Before Surfactant Treatment in Very Preterm Infants With RDS
NCT01996670 ·Status: COMPLETED